Drawing for ALLYSIAN SCIENCES

USPTO serial 86514920

ALLYSIAN SCIENCES

Reviewed by CopyMark Law Group

Reg. 5903392Status 710
Filing date
Status date
Registration date
Nov 5, 2019
Examiner
ANDERSON, CASSONDRA CR
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with ALLYSIAN SCIENCES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Trisha A. Doré

Trisha A. Doré Accupro Trademark Services LLP702 - 401 West Georgia StreetVancouver, BC, V6B5A1CANADA

Goods and services

ClassDescriptionStatusFirst use
005Nutritional supplements, namely, multivitamin preparations in pill form comprised of botanical extracts containing a nootropic formulation for the purpose of enhancing memory, cognition, focus, concentration, reaction time, learning, and comprehension; nutritional supplements, namely, multivitamin preparations in pill form comprised of botanical extracts containing a nootropic formulation for the purpose of improving mood and for reducing anxiety, depression, and mental fatigue; nutritional supplements, namely, a nootropic formulation in pill form comprised of botanical extracts for the purpose of enhancing memory, cognition, focus, concentration, reaction time, learning, and comprehension; nutritional supplements, namely, a nootropic formulation in pill form comprised of botanical extracts for the purpose of improving mood and for reducing anxiety, depression, and mental fatigue; dietary food supplements, namely, a nootropic formulation in pill form comprised of botanical extracts for the purpose of enhancing memory, cognition, focus, concentration, reaction time, learning, and comprehension; dietary food supplements, namely, a nootropic formulation in pill form comprised of botanical extracts for the purpose of improving mood and for reducing anxiety, depression, and mental fatigue; dietary food supplements, namely, multivitamin preparations in pill form comprised of botanical extracts containing a nootropic formulation for the purpose of enhancing memory, cognition, focus, concentration, reaction time, learning, and comprehension; dietary food supplements, namely, multivitamin preparations in pill form comprised of botanical extracts containing a nootropic formulation for the purpose of improving mood and for reducing anxiety, depression, and mental fatigue; nutritional supplements, namely, chocolate-based supplements in tablet form containing chocolate and botanical extracts for the purpose of enhancing memory, cognition, focus, concentration, reaction time, learning, and comprehension; nutritional supplements, namely, chocolate-based supplements in tablet form containing chocolate and botanical extracts for the purpose of improving mood and for reducing anxiety, depression, and mental fatigue; dietary supplements in powdered form containing botanical extracts, probiotic compositions, essential fatty acids, humic acids, and fulvic acids for the purpose of enhancing memory, cognition, focus, concentration, reaction time, learning, and comprehension; dietary supplements in powdered form containing botanical extracts, probiotic compositions, essential fatty acids, humic acids, and fulvic acids for the purpose of improving mood and for reducing anxiety, depression, and mental fatigueSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 15, 2026C8..CANCELLED SEC. 8 (6-YR)—
Nov 5, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jan 21, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jan 21, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Nov 5, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 1, 2019SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Sep 30, 2019CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Sep 18, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 17, 2019SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Sep 17, 2019EX1GSOU EXTENSION 1 GRANTED—
Sep 17, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jul 23, 2019NREVNOTICE OF REVIVAL - E-MAILED—
Jul 22, 2019IUAFUSE AMENDMENT FILED—
Jul 22, 2019EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jul 22, 2019TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Jul 22, 2019PETGPETITION TO REVIVE-GRANTED—
Jul 22, 2019PROATEAS PETITION TO REVIVE RECEIVED—
Jul 22, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 22, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 20, 2019MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 20, 2019ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 16, 2019EXT1SOU EXTENSION 1 FILED—
Oct 16, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 31, 2018TMBNTTAB RELEASE CASE TO TRADEMARKS—
Aug 31, 2018OP.TOPPOSITION TERMINATED NO. 999999—
Aug 31, 2018OP.DOPPOSITION DISMISSED NO. 999999—
Nov 3, 2015OP.IOPPOSITION INSTITUTED NO. 999999—
Aug 6, 2015ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jul 7, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 7, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 17, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 3, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 3, 2015ALIEASSIGNED TO LIE—
May 7, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 7, 2015XAECEXAMINER'S AMENDMENT ENTERED—
May 7, 2015GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 7, 2015GNEAEXAMINERS AMENDMENT E-MAILED—
May 7, 2015CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 30, 2015XAECEXAMINER'S AMENDMENT ENTERED—
Apr 30, 2015GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 30, 2015GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 30, 2015CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 29, 2015DOCKASSIGNED TO EXAMINER—
Feb 5, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 29, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance